Novo Total Revenue from 2010 to 2024

0QIU Stock   742.30  14.79  2.03%   
Novo Nordisk Total Revenue yearly trend continues to be comparatively stable with very little volatility. Total Revenue will likely drop to about 134.9 B in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Novo Nordisk's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
161.9 B
Current Value
134.9 B
Quarterly Volatility
15.7 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novo Nordisk financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novo Nordisk's main balance sheet or income statement drivers, such as Tax Provision of 11.3 B, Interest Income of 1.3 B or Interest Expense of 0.0, as well as many indicators such as . Novo financial statements analysis is a perfect complement when working with Novo Nordisk Valuation or Volatility modules.
  
This module can also supplement various Novo Nordisk Technical models . Check out the analysis of Novo Nordisk Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novo Stock Analysis

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.